The European Federation of Pharmaceutical Industries and Associations (EFPIA) has unveiled a Swedish pilot project to verify medicines and so help reduce the risk of counterfeit medicines being dispensed to patients. The verification system is being piloted in conjunction with project partners Apoteket AB, the Swedish pharmaceutical retailer, and local wholesalers, Tamro and Oriola-KD.
Using a small data matrix - similar to a barcode - to individually number each pack of medicine, the system can provide the pharmacist with an almost instantaneous verification as to whether a pack has been previously dispensed. A confirmation will immediately alert them to the risk that the pack may be counterfeit, the trade body notes.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze